As of February 2026, both compounds have been reclassified as Category 1 peptides, meaning they may be compounded by licensed compounding pharmacies under a physician prescription
Weight loss tends to be gradual
These lawsuits are part of a multidistrict litigation (MDL) against GLP-1 drug manufacturers
Based on observations from bariatric surgery literature, rapid loss of adipose tissue alters body mechanics, weight distribution, and postural alignment
That's why we have built a rigorous system of pharmacy oversight and quality assurance that aligns with the highest industry standards
Advantages No injection required Simple, convenient administration May provide some local benefit to the gastrointestinal tract before degradation Easier for people with needle aversion Disadvantages Substantially lower systemic bioavailability Inconsistent absorption from dose to dose Higher doses needed to achieve similar systemic effects (if achievable at all) Limited evidence for systemic benefits via oral route Potential GI effects from higher doses Emerging Solutions Some manufacturers are exploring encapsulation technologies, enteric coatings, and liposomal delivery systems designed to protect oral peptides from digestive degradation